| Item Type | Name |
|
Concept
|
Randomized Controlled Trials as Topic
|
|
Academic Article
|
Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions.
|
|
Academic Article
|
Advances and continued controversy in coronary revascularization of patients with diabetes mellitus.
|
|
Academic Article
|
Glycoprotein IIb/IIIa receptor antagonists: a comparative review of their use in percutaneous coronary intervention.
|
|
Academic Article
|
Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methods.
|
|
Academic Article
|
Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials.
|
|
Academic Article
|
Aspirin dose and six-month outcome after an acute coronary syndrome.
|
|
Academic Article
|
Association of the timing of ST-segment resolution with TIMI myocardial perfusion grade in acute myocardial infarction.
|
|
Academic Article
|
Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview.
|
|
Academic Article
|
Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
|
|
Academic Article
|
Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials.
|
|
Academic Article
|
Interventional cardiovascular pharmacotherapy: current issues.
|
|
Academic Article
|
Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes.
|
|
Academic Article
|
The early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation acute coronary syndrome (EARLY ACS) trial: a randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non-ST-segment elevation acute coronary syndrome--study design and rationale.
|
|
Academic Article
|
The PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics.
|
|
Academic Article
|
Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes.
|
|
Academic Article
|
Outcomes of patients in clinical trials with ST-segment elevation myocardial infarction among countries with different gross national incomes.
|
|
Academic Article
|
Cardiac tamponade in the fibrinolytic era: analysis of >100,000 patients with ST-segment elevation myocardial infarction.
|
|
Academic Article
|
A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes.
|
|
Academic Article
|
Statin use and sex-specific stroke outcomes in patients with vascular disease.
|
|
Academic Article
|
Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial.
|
|
Academic Article
|
The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials.
|
|
Academic Article
|
Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trials.
|
|
Academic Article
|
Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
|
|
Academic Article
|
International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromes.
|
|
Academic Article
|
Comparative effectiveness of angiotensin-converting-enzyme inhibitors: is an ACE always an ace?
|
|
Academic Article
|
Premature release of data from clinical trials of ezetimibe.
|
|
Academic Article
|
Sex differences in mortality following acute coronary syndromes.
|
|
Academic Article
|
Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial.
|
|
Academic Article
|
ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
|
|
Academic Article
|
Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trials.
|
|
Academic Article
|
Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery.
|
|
Academic Article
|
Incidence and clinical significance of cardiac biomarker elevation during stem cell mobilization, apheresis, and intramyocardial delivery: an analysis from ACT34-CMI.
|
|
Academic Article
|
A novel approach to systematically implement the universal definition of myocardial infarction: insights from the CHAMPION PLATFORM trial.
|
|
Academic Article
|
Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data.
|
|
Academic Article
|
Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis.
|
|
Academic Article
|
Heart failure complicating non-ST-segment elevation acute coronary syndrome: timing, predictors, and clinical outcomes.
|
|
Academic Article
|
Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial.
|
|
Academic Article
|
Investigator-Reported Bleeding Versus Post Hoc Adjudication of Bleeding: Lessons From the CHAMPION PHOENIX Trial.
|
|
Academic Article
|
Coronary Artery Bypass Surgery Is Not Underutilized!
|
|
Academic Article
|
Trends in Enrollment, Clinical Characteristics, Treatment, and Outcomes According to Age in Non-ST-Segment-Elevation Acute Coronary Syndromes Clinical Trials.
|
|
Academic Article
|
Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial.
|
|
Academic Article
|
The Changing Landscape of Randomized Clinical Trials in Cardiovascular Disease.
|
|
Academic Article
|
Impact of Cerebrovascular Events Older Than One Year on Ischemic and Bleeding Outcomes With Cangrelor in Percutaneous Coronary Intervention.
|
|
Academic Article
|
The Systematic Evaluation of Identifying the Infarct Related Artery Utilizing Cardiac Magnetic Resonance in Patients Presenting with ST-Elevation Myocardial Infarction.
|
|
Academic Article
|
When academic research organizations and clinical research organizations disagree: Processes to minimize discrepancies prior to unblinding of randomized trials.
|
|
Academic Article
|
Short- and long-term mortality following bleeding events in patients undergoing percutaneous coronary intervention: insights from four validated bleeding scales in the CHAMPION trials.
|
|
Academic Article
|
Incidence, Predictors, and Outcomes of Acquired Thrombocytopenia After Percutaneous Coronary Intervention: A Pooled, Patient-Level Analysis of the CHAMPION Trials (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition).
|
|
Academic Article
|
Rediscovering the Orbit of Percutaneous Coronary Intervention After ORBITA.
|
|
Academic Article
|
Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous?Coronary Intervention.
|
|
Academic Article
|
International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.
|
|
Academic Article
|
Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial.
|
|
Academic Article
|
Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trial.
|
|
Academic Article
|
Planning and Conducting the ISCHEMIA Trial.
|
|
Academic Article
|
Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial.
|
|
Academic Article
|
Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study.
|
|
Academic Article
|
Periprocedural Outcomes According to Timing of Clopidogrel Loading Dose in Patients Who Did Not Receive P2Y12 Inhibitor Pretreatment.
|
|
Academic Article
|
Central Adjudication Identified Additional and Prognostically Important Myocardial Infarctions in Patients Undergoing Percutaneous Coronary Intervention.
|
|
Academic Article
|
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials.
|
|
Academic Article
|
The failure of orally administered glycoprotein IIb/IIIa inhibitors to prevent recurrent cardiac events.
|
|
Academic Article
|
Early angioplasty in acute coronary syndromes without persistent ST-segment elevation improves outcome but increases the need for six-month repeat revascularization: an analysis of the PURSUIT Trial. Platelet glycoprotein IIB/IIIA in Unstable angina: Receptor Suppression Using Integrilin Therapy.
|
|
Academic Article
|
Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes.
|
|
Academic Article
|
Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B).
|
|
Academic Article
|
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
|
|
Academic Article
|
Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
|
|
Academic Article
|
Generating evidence for therapeutic effects: the need for well-conducted randomized trials.
|
|
Academic Article
|
Trends in clinical trials of non-ST-segment elevation acute coronary syndromes over 15 years.
|
|
Academic Article
|
Transforming clinical trials in cardiovascular disease: mission critical for health and economic well-being.
|
|
Academic Article
|
No misrepresentation of vital status follow-up in PLATO: predefined analyses guarantee the integrity of the benefits of ticagrelor over clopidogrel in the PLATO trial: Commentary on: DiNicolantonio JJ, Tomek A, Misrepresentation of vital status follow-up: challenging the integrity of the PLATO trial and the claimed mortality benefit of ticagrelor versus clopidogrel, International Journal of Cardiology, 2013 Serebruany VL. Discrepancies in the primary PLATO trial publication and the FDA review...
|
|
Academic Article
|
Radial access in patients with acute coronary syndrome without persistent ST-segment elevation: Systematic review, collaborative meta-analysis, and meta-regression.
|
|
Academic Article
|
Potent P2Y12 Inhibitors in Men?Versus?Women: A?Collaborative?Meta-Analysis?of?Randomized?Trials.
|
|
Academic Article
|
Randomized Trials Versus Common?Sense and Clinical Observation: JACC Review Topic of the Week.
|
|
Academic Article
|
Assessment of North American Clinical Research Site Performance During the Start-up of Large Cardiovascular Clinical Trials.
|